Anti-ErbB2 [ICR12]
Invented at The Institute of Cancer Research
- Datasheet
- References (4)
- Inventor Info
Info
| Catalogue Number | 153389 |
| Applications | IP |
| Antigen/Gene or Protein Targets | Erb-B2 |
| Synonyms | ERBB2; Tyrosine kinase type cell surface receptor HER2 |
| Reactivity | Human |
| Relevance | Protein tyrosine kinase that is part of several cell surface receptor complexes, but that apparently needs a coreceptor for ligand binding. Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Regulates outgrowth and stabilization of peripheral microtubules (MTs). Upon ERBB2 activation, the MEMO1-RHOA-DIAPH1 signaling pathway elicits the phosphorylation and thus the inhibition of GSK3B at cell membrane. This prevents the phosphorylation of APC and CLASP2, allowing its association with the cell membrane. In turn, membrane-bound APC allows the localization of MACF1 to the cell membrane, which is required for microtubule capture and stabilization. |
| Host | Rat |
| Immunogen | breast carcinoma cell line BT474 |
| Subclass | IgG2a |
| Molecular Weight (kDa) | 77 |
| Research Area | Cancer, Cell Type or Organelle Marker, Cell Signaling & Signal Transduction |
References: 4 entries
Smellie et al. 1995. Cancer Res. 55(23 Suppl):5842s-5846s. PMID: 7493357.
Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods.
Europe PMC ID: 7493357
Eccles et al. 1994. Cancer Res. 54(19):5171-7. PMID: 7923136.
Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185.
Europe PMC ID: 7923136
Add a reference
References: 4 entries
Smellie et al. 1995. Cancer Res. 55(23 Suppl):5842s-5846s. PMID: 7493357.
Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods.
Eccles et al. 1994. Cancer Res. 54(19):5171-7. PMID: 7923136.
Regression of established breast carcinoma xenografts with antibody-directed enzyme prodrug therapy against c-erbB2 p185.
Add a reference
